Crizotinib versus chemotherapy: a real-world cost-effectiveness study in China.
Huang M, Tian Y, He M, Liu J, Ren L, Gong Y, Peng F, Wang Y, Ding Z, Wang J, Zhu J, Xu Y, Liu Y, Li L, Lu Y.
Huang M, et al. Among authors: xu y.
J Comp Eff Res. 2020 Jan;9(2):93-102. doi: 10.2217/cer-2019-0075. Epub 2020 Jan 21.
J Comp Eff Res. 2020.
PMID: 31958984
Free article.